263
Participants
Start Date
January 5, 2018
Primary Completion Date
January 22, 2022
Study Completion Date
December 31, 2025
Selinexor
Dose: 80 mg (4 tablets) or 60 mg (3 tablets); Dosage form: film-coated, immediate-release tablet of 20 mg each; Route of administration: oral
Matching placebo for selinexor
Dose: 80 mg (4 tablets) or 60 mg (3 tablets); Dosage form: film-coated, immediate-release tablet of 20 mg each; Route of administration: oral
AZ Turnhout, Turnhout
Universitaire Ziekenhuizen K.U. Leuven, Leuven
CHR Verviers, Verviers
CHU UCL Namur, Site Sainte-Elisabeth, Namur
Jan Yperman Ziekenhuis, Ieper
UZ Gent, Ghent
NYU Langone, New York
UH Královské Vinohrady, Prague
Istituto di Candiolo, FPO, IRCCS, Candiolo
Memorial Sloan Kettering Cancer Center, New York
ALEXANDRA Hospital, Athens
General University Hospital in Prague, Prague
Charite Berlin Universitatsmedizin, Berlin
Hospital Na Bulovce, Prague
Hospital Universitario Donostia, San Sebastián
San Raffaele Hospital, Milan
Istituto Nazionale dei Tumori IRCCS - MILANO S.C. Ginecologia Oncologica, Milan
VCU Massey Cancer Center, Richmond
Universitatsklinikum Schleswig-Holstein, Kiel
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario Puerta de Hierro - Majadahonda, Madrid
Hospital Universitario Infanta Sofía, Madrid
Virgen de la Arrixaca University Clinical Hospital, Murcia
Agostino Gemelli University Polyclinic Foundation, Rome
DIAKOVERE KH gGmbH, Henriettenstift Hannover, Hanover
ULSS 3 SERENISSIMA UOC Oncologia Ed Ematologia Oncologica, Mirano
Florida Cancer Specialists (Sarah Cannon Research Institute), West Palm Beach
Moffitt Cancer Center, Tampa
Tennessee Oncology Nashville (Sarah Cannon Research Institute), Nashville
Hillel Yaffe Medical Center, Hadera
Hospital Universitario Virgen del Rocío, Seville
Instituto Valenciano de Oncología, Valencia
Hospital Clínico Universitario de Valencia, Valencia
Hospital Universitario y Politécnico de La Fe, Valencia
Indiana University Simon Cancer Center, Indianapolis
Parkview Research Center, Fort Wayne
Romagnolo Scientific Institute for the Study and Treatment of Tumors, Meldola
Hospital Clínico Universitario Lozano Blesa, Zaragoza
Sheba Medical Center, Ramat Gan
Euromedica General Clinic, Thessaloniki
Universitätsfrauenklinik Mainz, Mainz
Wolfson Medical Center, Holon
University Hospital Brno, Brno
Gynecological Cancer Institute of Chicago, Oak Lawn
HCA Midwest Health - Kansas City (Sarah Cannon Research Institute), Kansas City
Cartitas Klinikum Saarbrücken, Saarbrücken
University Hospital Ostrava, Ostrava
University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City
Texas Oncology DFW, Dallas
University of Texas Southwestern Medical Center, Dallas
Texas Oncology DFW, Fort Worth
Texas Oncology, Austin, Austin
"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale - NAPOLI Struttura Complessa Oncologia Medica Uro-Ginecologica", Naples
Klinikum der Universitat Munchen, Munich
Arizona Oncology, Tucson
Universitätsfrauenklinik Ulm, Ulm
Stanford University, Palo Alto
Oncology Associates of Oregon, Eugene
Peking Union Medical College Hospital, Beijing
Liaoning Cancer Hospital, Shenyang
Harbin Medical University Cancer Hospital, Harbin
Wenzhou Medical University - The First Affiliated Hospital, Wenzhou
Jiangxi Maternal and Child Health Hospital, Nanchang
Chongqing University Cancer Hospital, Chongqing
Shaare Zedek Medical Center, Jerusalem
Hadassah Medical Center, Jerusalem
Women & Infants Hospital of Rhode Island, Providence
London Health Sciences Centre (London Regional Cancer Centre), London
University Health Network (PMCC), Toronto
McGill University Health Centre (MUHC), Montreal
Henan Cancer Hospital, Zhengzhou
Hunan Cancer Hospital, Changsha
University Hospital Dresden, Dresden
Iaso Hospital, Marousi
Hospital Universitari Vall d' Hebrón, Barcelona
Hospital Universitari Clínic de Barcelona, Barcelona
Consorci Sanitari de Terrassa, Barcelona
Hospital Son Llàtzer, Palma
Lead Sponsor
Belgian Gynaecological Oncology Group
OTHER
North-Eastern German Society of Gynaecologic Oncology
UNKNOWN
Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies
UNKNOWN
Spanish Research Group in Ovarian Cancer
UNKNOWN
The Central and Eastern European Gynecologic Oncology Group
OTHER
Israeli Society of Gynecologic Oncology
OTHER
GOG Foundation
NETWORK
Karyopharm Therapeutics Inc
INDUSTRY